Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
23.90
+0.24 (1.01%)
At close: Sep 4, 2026, 4:00 PM EDT
24.61
+0.71 (2.97%)
After-hours: Sep 4, 2026, 5:20 PM EDT
Arcutis Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $34 | Buy | Reiterates | $34 | +42.26% | Aug 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $34 → $38 | Buy | Reiterates | $34 → $38 | +59.00% | Aug 6, 2026 |
| Needham | Needham | Buy Reiterates $40 | Buy | Reiterates | $40 | +67.36% | Aug 6, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $35 → $38 | Buy | Reiterates | $35 → $38 | +59.00% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $35 | Buy | Maintains | $35 | +46.44% | Aug 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $35 → $36 | Buy | Reiterates | $35 → $36 | +50.63% | Aug 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $35 | Buy | Maintains | $35 | +46.44% | Jul 9, 2026 |